Which mutual funds are scoring high on value, quality and momentum factors: Insights from Share.Market's MF scorecard

Live Events
Mutual fund houses like Nippon India Mutual Fund, HDFC Mutual Fund , ICICI Prudential Mutual Fund, and Franklin Templeton Mutual Fund emerged as the most consistent performers across fund categories. PPFAS Mutual Fund 's two equity funds also stood out for their consistent performance, with a strong focus on Quality and Value factors.On the other hand, most of the funds of quant AMC also score 'high' on performance consistency, their funds seem to have significantly higher risk than peers in the respective categories, according to Share.Market's CRISP Mutual Funds Scorecard.Based on balanced factor exposure yields results, AMCs like ICICI Prudential Mutual Fund, SBI Mutual Fund , and Nippon India Mutual Fund demonstrated strong performance consistency without extreme tilt towards a single investment style, highlighting the effectiveness of balanced strategies, stock selection, and asset allocation Also Read | Smallcap mutual funds emerge as top performers in May with average return of 8%. Opportunity or time for caution? Based on value & momentum styles outperformance, funds with high exposure to Value and Momentum investment styles outperformed across most categories over the past five years, the scorecard highlighted.In the Large & Midcap Funds category, approximately 56% of the funds categorised as high on value style are also high on consistency, and 22% are 'high' on momentum. In the ELSS category, around 55% of the funds with 'high' performance consistency had a 'high' score on value style, and 45% had a 'high' score on momentum.Other core categories, such as flexicap and large cap, have also witnessed a similar trend, with the majority of 'high' consistency performers being 'high' on value and/or momentum investment styles.The report also highlights that there are instances of funds that, despite maintaining 'High' exposure to styles that have driven performance over the last 5 years, i.e. High Value and/or High Momentum, have not been able to translate this into strong Consistency scores. This highlights the fact that favourable style factors alone do not guarantee top-tier results.Also Read | Should you consider starting SIP or lumpsum in a momentum index fund right now? 'Investors today are overwhelmed with data, but much of it stops at historical returns or risk-adjusted ratings—often leaving them with limited information for investment decision making. At Share.Market, we believe investors deserve more. With our CRISP Mutual Funds Scorecard, we go beyond past performance to offer deeper, actionable insights into how their money is truly being managed. This initiative reflects our commitment to empowering investors with a clearer, more holistic view of mutual fund performance,' said Ujjwal Jain, CEO, Share.Market.Share.Market (PhonePe Wealth) released the inaugural edition of its 'CRISP Mutual Funds Scorecard' for the quarter ending March 2025 (data considered is for the period April '20 to March '25) today.The CRISP Mutual Funds Scorecard is a quarterly, data-driven evaluation of mutual funds across categories and AMCs, offering investors a comprehensive view of performance, risk, and investment style.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

2 days ago

• Business Standard

Biocon raises Rs 4,500 crore via QIP

First equity fundraise since 2004 IPO sees strong institutional demand. Biocon has successfully concluded a Qualified Institutions Placement (QIP), raising Rs 4,500 crore (approximately $523 million), marking its first equity fundraise since its IPO in 2004. The company issued 13.63 crore equity shares at Rs 330 per share. The QIP opened on June 16 and closed on June 19, attracting participation from a mix of domestic and foreign institutional investors. Major names in the final orderbook included SBI Mutual Fund, ICICI Prudential Mutual Fund, HDFC Life, Nippon India Mutual Fund, Mirae Asset, Franklin Templeton, SBI General Insurance, Government Pension Fund Global, and BlackRock. The proceeds from the fundraise will be used for multiple strategic objectives, including purchasing optionally convertible debentures of Biocon Biologics from Goldman Sachs-managed funds, repaying certain borrowings, and meeting other financial and corporate needs. Following the issue, the combined stake of the promoter and promoter group stands at 54.45%, down from 60.64% as of March 2025. Siddharth Mittal, CEO and managing director, Biocon, said, "The strong response to our QIP reflects deep investor conviction in Biocon's differentiated strategy and consistent execution. This capital raise further strengthens our balance sheet, enabling us to invest in innovation, expand global access to lifesaving biopharmaceuticals, and advance our purpose of delivering affordable healthcare solutions that address pressing health inequities worldwide." Biocon is a global biopharma company dedicated to improving affordable access to therapies for chronic conditions like diabetes, cancer, and autoimmune diseases. The companys consolidated net profit surged 154.2% to Rs 344.50 crore on a 12.8% jump in net sales to Rs 4,358.10 crore in Q4 FY25 over Q4 FY24. The scrip rose 0.86% to settle at Rs 351.60 on Friday, 20 June 2025.

India Today

3 days ago

• India Today

Stocks to watch today: Oswal Pumps, Biocon, United Spirits, Sai Life Sciences

Stock markets remained volatile and ended flat on Wednesday, as investors stayed cautious due to weak global cues and growing tension in the Middle East. On Friday, a mix of company updates and investor actions may influence specific stocks on Dalal a major player in the biopharmaceutical industry, has closed its qualified institutional placement (QIP) issue. The company finalised the allotment of 13.63 crore shares, raising Rs 4,500 crore. These shares were allotted at Rs 330 each. Notable investors in the QIP include ICICI Prudential Mutual Fund, SBI Mutual Fund, HDFC Life Insurance, Nippon Life India, Mirae Asset, and Franklin SpiritsUnited Spirits has announced that it will buy 37,683 equity shares of Nao Spirits & Beverages in two parts from existing shareholders. The cost of this acquisition is Rs 53.80 crore. In addition to this, United Spirits will subscribe to 31,820 new equity shares and 27,577 compulsorily convertible preference shares (CCPS) for Rs 56 crore. Once the first part of this transaction is completed, United Spirits will own 97.07% of Nao Spirits, making it a Life SciencesSai Life Sciences may see movement today as TPG Asia VII SF Pte is expected to sell a 6% stake in the company. This translates to around 1.25 crore shares, according to a CNBC-TV18 report. The deal is likely to be worth about USD 102 million, with a base price set at Rs 710 per share. The block deal could draw attention from institutional investors and Technology IndiaKaynes Technology has launched its QIP on June 19. The floor price has been fixed at Rs 5,625.75 per share. According to sources quoted by CNBC-TV18, the company aims to raise up to Rs 1,600 crore through this offer. The QIP is likely to help the company with expansion plans or strengthen its IndiaShares of Nestle India could be in focus after the company announced that its Board of Directors will meet on June 26. They will consider a proposal to issue bonus shares. Investors will watch this development closely, as bonus shares usually lead to positive market OneDevender Kumar, the Chief Revenue Officer of Direct Business at Angel One, has resigned. His last working day will be September 30. Management changes at senior levels often affect investor confidence and may have a short-term impact on stock shares may be under pressure after Goldman Sachs sold more than 1.77 lakh shares through a block deal. The total deal size was Rs 48 crore, with the shares sold at a price of Rs 2,700.6 PumpsThough the listing is expected on June 20, market participants will watch Oswal Pumps closely. Its IPO received strong demand across all investor categories, and the grey market premium has hinted at a positive listing. Final price movement on debut will give an indication of investor confidence in the these updates, markets may see stock-specific action even as broader cues remain uncertain. advertisement

Time of India

4 days ago

• Time of India

India-UK social security pact was non-negotiable in free trade deal: Piyush Goyal

New Delhi: The India-UK social security agreement was made a non-negotiable part of the free trade agreement (FTA) discussions two years ago, commerce and industry minister Piyush Goyal said on Wednesday. Termed the Double Contribution Convention Agreement (DCCA), it was agreed to along with the FTA between the two countries in May. "It was on the table for the last three years to bring balance and equity and balance to the trade deal between the two economies," Goyal said at an event in London. The minister is on a two-day visit to London from Wednesday. The agreement exempts Indian professionals and their employers from paying social security contributions in the UK for short-term assignments of up to three years. The pact will allow temporary Indian workers in UK to pay their social security contributions in India for the first year and for two years nothing will be collected from them. At the same event, UK secretary of state for business and trade Jonathan Reynolds said it is a business mobility provision which the UK has with every country for persons coming temporarily for business or MNCs posting staff in UK. "With 50 other countries we have extended the provision. It is reciprocal so UK nationals employed by those companies in India pay into our system (for one year)." Live Events Goyal said since temporary professionals stay less than the 10 year threshold to qualify for receiving benefits against their social security contributions in the UK, this money otherwise won't be paid back to them.